Close Menu

Researchers are not so good at gauging whether a clinical trial will be successful, Stat News reports.

A team led by McGill University's Jonathan Kimmelman asked cancer researchers to predict whether certain clinical trials would make their primary endpoint, Stat News says, noting that the work isn't yet published. It adds that the cancer researchers queried tended to underestimate trials that would meet their endpoints.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.